Clinical Trial News Archive - August 2023
August 1, 2023
August 2, 2023
August 3, 2023
- U.S. CDC Advisory Committee Unanimously Recommends Routine Use of Beyfortus (nirsevimab-alip) to Protect Infants Against RSV Disease
- Vertex Announces Publication of VX-548 Positive Phase 2, Proof-of-Concept Results in New England Journal of Medicine
- Aardvark Receives FDA Rare Pediatric Disease Designation for Prader-Willi Syndrome and Expands the Ongoing Phase 2 Clinical Trial
August 4, 2023
August 7, 2023
- Vistagen Announces Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder
- Anixa Biosciences Announces Opening of Enrollment for Keytruda Arm in Ongoing Breast Cancer Vaccine Clinical Trial
August 8, 2023
- Positive Clinical Results With FMXIN002 Intranasal Powder Epinephrine Spray
- Novo Nordisk A/S: Semaglutide 2.4 mg Reduces the Risk of Major Adverse Cardiovascular Events by 20% in Adults with Overweight or Obesity in the SELECT Trial
August 9, 2023
- Nanoscope Therapeutics Unveils Clinical Trial Results for MCO-010 in Treating Stargardt Disease
- Novartis Remibrutinib Phase III Trials Met Their Primary Endpoints and Showed Rapid Symptom Control in Chronic Spontaneous Urticaria
- Positive Preclinical End Point Results of HT-ALZ Treatment for Alzheimer's Disease
August 10, 2023
August 11, 2023
August 14, 2023
- Valneva Announces PDUFA Date Extension for Chikungunya Virus Vaccine Candidate
- First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
August 15, 2023
- Sandoz Announces Positive Results from Mylight Phase lll Study for Biosimilar Aflibercept
- Clinical Trial Results Support Genetic Testing of All Patients with Prostate Cancer
August 16, 2023
- IDEAYA Announces First-Patient-In for Company-Sponsored Phase 2 Clinical Trial Evaluating Darovasertib in (Neo)Adjuvant Uveal Melanoma
- Sandoz Announces Positive Results from Mylight Phase lll Study for Biosimilar Aflibercept
- Updated Data from TRIDENT-1 Trial Show Durable Efficacy Benefits with Repotrectinib for Patients with Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
August 17, 2023
August 18, 2023
August 21, 2023
- Gilead Announces Partial Clinical Hold for Magrolimab Studies in AML
- FIRST PATIENT DOSED WITH ZE46-0134, A SELECTIVE FLT3wt-SPARING, PAN FLT3mut INHIBITOR
August 22, 2023
- Positive Phase 1/2 Clinical Trial Results of Genethon’s Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease, Published in The New England Journal of Medicine
- Retevmo Demonstrates Superior Progression-Free Survival Compared to Approved Multikinase Inhibitors in RET-Mutant Medullary Thyroid Cancer
- Genentech Provides Update on Phase III Skyscraper-01 Study of Tiragolumab Plus Tecentriq in PD-L1-High Metastatic Non-Small Cell Lung Cancer
August 23, 2023
August 24, 2023
- NKGen Biotech, Inc. Announces First Patient Dosed in Phase I Clinical Trial of SNK02, Allogeneic NK Cell Therapy Product Candidate, for the Treatment of Solid Tumors
- Global Consortium Identifies Novel Parkinson's Genetic Risk Factor in African Populations
August 25, 2023
August 26, 2023
August 29, 2023
- Faron Receives FDA Orphan Drug Designation for Bexmarilimab in Acute Myeloid Leukemia
- New INGREZZA Capsules Data Demonstrates Early and Sustained Improvements in Chorea Associated With Huntington's Disease
August 30, 2023
Clinical trial results archive
- 2024
- January, February, March, April, May, June, July, August, September, October, November, December
- 2023
- January, February, March, April, May, June, July, August, September, October, November, December
- 2022
- January, February, March, April, May, June, July, August, September, October, November, December
- 2021
- January, February, March, April, May, June, July, August, September, October, November, December
- 2020
- January, February, March, April, May, June, July, August, September, October, November, December
- 2019
- January, February, March, April, May, June, July, August, September, October, November, December
- 2018
- January, February, March, April, May, June, July, August, September, October, November, December
- 2017
- May, June, July, August, September, October, November, December
- 2016
- October
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.